CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-26 | JACOBS CINDY President & CMO | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-01-26 | Clarke Anthony CSO | Grant or award · Performance Restricted Stock Unit (PRSU) | +2,000 | 2,000 | ||
| 2021-01-26 | Clarke Anthony CSO | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2021-01-26 | Bencich John CEO | Grant or award · Performance Restricted Stock Unit (PRSU) | +15,000 | 15,000 | ||
| 2021-01-26 | Bencich John CEO | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2020-11-16 | Wann Jerry Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2020-11-16 | Clarke Anthony CSO | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2020-11-16 | Stewart Richard Alistair Executive Chairman | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-11-16 | JACOBS CINDY President & CMO | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2020-11-16 | Bencich John CEO | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-08-18 | Bencich John CFO & COO | Option exercise | +69 | 174 | ||
| 2020-08-18 | Bencich John CFO & COO | Shares withheld for taxes | −33 | $8.95 | $295 | 141 |
| 2020-08-18 | Bencich John CFO & COO | Option exercise · Restricted Stock Unit (RSU) | −69 | 68 | ||
| 2020-08-18 | JACOBS CINDY EVP, CMO | Option exercise | +69 | 209 | ||
| 2020-08-18 | JACOBS CINDY EVP, CMO | Shares withheld for taxes | −33 | $8.95 | $295 | 176 |
| 2020-08-18 | JACOBS CINDY EVP, CMO | Option exercise · Restricted Stock Unit (RSU) | −69 | 68 | ||
| 2020-05-12 | MATTINGLY MARTIN A Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2020-05-12 | Cormack Scott Daniel Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2020-05-12 | MOYES JAY M Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2020-05-12 | PARKER H STEWART Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 |
Page 13 of 36 · 715 trades